Nevertheless, the TXL, Ato, and TXL–Ato groups had substantially reduced VCAM‐1 and ICAM‐1 mRNA levels compared to the COPD + AS group. The gene discussed is TXNL1; the disease is chronic obstructive pulmonary disease.